The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Research Funding - Xodus Medical
Travel, Accommodations, Expenses - Intuitive Surgical
Analysis of patient-reported outcomes (PROs) for GOG-258, a randomized phase III trial of cisplatin and tumor volume directed irradiation followed by carboplatin and paclitaxel (Cis-RT+CP) vs. carboplatin and paclitaxel (CP) for optimally debulked, locally advanced endometrial carcinoma: A Gynecologic Oncology Group/NRG study.
 
Ursula A. Matulonis
Consulting or Advisory Role - 2X Oncology; Clovis Oncology; Fujifilm; Geneos; Lilly; Merck; Myriad Genetics
Research Funding - Merck; Novartis
 
Virginia L. Filiaci
No Relationships to Disclose
 
Helen Q Huang
No Relationships to Disclose
 
Marcus Randall
Honoraria - Isoray
 
Byoung Kim
No Relationships to Disclose
 
Paul DiSilvestro
Consulting or Advisory Role - AstraZeneca; Tesaro
Research Funding - Abbvie (Inst); AstraZeneca (Inst); Genentech (Inst); Janssen (Inst); Tesaro (Inst)
 
Katherine M. Moxley
No Relationships to Disclose
 
David M. O'Malley
Honoraria - Clovis Oncology
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca; Clovis Oncology; Janssen Oncology; Myriad Genetics; Novocure; Tesaro
Research Funding - Agenus (Inst); Ajinomoto (Inst); Amgen (Inst); Array BioPharma (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Cerulean Pharma (Inst); Clovis Oncology (Inst); EMD Serono (Inst); Ergomed (Inst); Genentech/Roche (Inst); Immunogen (Inst); Immunogen (Inst); Janssen Research & Development (Inst); PharmaMar (Inst); Regeneron (Inst); Stem CentRx (Inst); Tesaro (Inst); TRACON Pharma (Inst); VentiRx (Inst)
 
Matthew A. Powell
Consulting or Advisory Role - AstraZeneca; Roche/Genentech
Speakers' Bureau - AstraZeneca; Genentech/Roche
 
Nicola M. Spirtos
Research Funding - Abbvie (Inst); AstraZeneca (Inst); Genentech/Roche (Inst)
 
Krishnansu Sujata Tewari
Consulting or Advisory Role - Roche/Genentech
Speakers' Bureau - AstraZeneca; Merck; Roche/Genentech
Travel, Accommodations, Expenses - Roche/Genentech
 
William Richards
No Relationships to Disclose
 
John Nakayama
No Relationships to Disclose
 
Margaret Steinhoff
No Relationships to Disclose
 
David Gardner Mutch
Honoraria - Clovis Oncology
Consulting or Advisory Role - lilly
Speakers' Bureau - AstraZeneca
 
David S. Miller
No Relationships to Disclose
 
Lari B. Wenzel
Consulting or Advisory Role - Array BioPharma; Array BioPharma
 
Daniela Matei
Honoraria - Astex Pharmaceuticals; AstraZeneca; Clovis Oncology; Genentech/Roche
Consulting or Advisory Role - Astex Pharmaceuticals; AstraZeneca; Clovis Oncology; Roche/Genentech
Research Funding - Merck; Merck
Travel, Accommodations, Expenses - AstraZeneca; Genentech/Roche